Headline Details

Merck KGaA lung cancer drug is 3rd on U.S. watchdog's priority lane

Published on: Wed, 11 Sep 2019 8:00:23 UTC
News Agency: Reuters
Description:
Merck KGaA's prospective lung cancer treatment tepotinib became the third drug against a rare and aggressive subtype of the disease that won U.S. Food and Drug Administration's breakthrough therapy designation.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
Israel-Gaza: Tensions high as violence continues BBC
Alireza: Alleged killing of Iranian gay man sparks outcry BBC
Eid 2021: Muslims celebrate the end of Ramadan BBC
Pierre-Charles Boudot: Top French jockey under investigation for rape BBC
Israel-Gaza: Deaths mount as Israel-Gaza violence worsens BBC